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Abstract 
A novel candidate tumor suppressor gene (TSG), Cysteine-rich intestine protein 2 (CRIP2), 
was identified in NPC. This gene has previously been reported to be expressed in the heart 
endothelium; its possible relationship with tumor development is unknown. Therefore, its 
contribution and functional role in NPC was investigated. Methods/Principal findings: 
CRIP2 is down-regulated in 5/7 NPC cell lines and 42/60 (70%) patient biopsies. CRIP2 re-
expression suppresses colony formation in vitro and tumor growth in vivo. Functional studies 
such as invasion, HUVEC tube formation, and in vivo matrigel plug angiogenesis assays 
were used to investigate CRIP2 gene function. Expression of CRIP2 inhibits angiogenesis 
both in vitro and in vivo. Using an angiogenesis protein array, several angiogenesis-related 
proteins were found to be down-regulated by CRIP2 re-expression. Analysis of conditioned 
media and gene expression in CRIP2-expressing clones validated protein array analysis 
results. Conclusions and Significance: An interesting candidate TSG, CRIP2, was 
identified. Functional studies confirm that CRIP2 can suppress tumor growth in vivo and 
inhibit angiogenesis. Angiogenesis is important for cancer development; inhibition of 
angiogenesis by CRIP2, which down-regulates the angiogenesis and VEGF signaling 
pathway proteins further confirms its importance in tumor development in NPC. CRIP2 is a 
potential candidate for future NPC therapeutic treatment. 
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